BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26666338)

  • 1. Lucidimine A-D, four new alkaloids from the fruiting bodies of Ganoderma lucidum.
    Zhao ZZ; Chen HP; Feng T; Li ZH; Dong ZJ; Liu JK
    J Asian Nat Prod Res; 2015; 17(12):1160-5. PubMed ID: 26666338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triterpenoids from the fruiting bodies of Ganoderma lucidum and their inhibitory activity against FAAH.
    Lin YX; Sun JT; Liao ZZ; Sun Y; Tian XG; Jin LL; Wang C; Leng AJ; Zhou J; Li DW
    Fitoterapia; 2022 Apr; 158():105161. PubMed ID: 35217118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lanostane triterpenes from the fruiting bodies of Ganoderma lucidum and their inhibitory effects on adipocyte differentiation in 3T3-L1 Cells.
    Lee I; Seo J; Kim J; Kim H; Youn U; Lee J; Jung H; Na M; Hattori M; Min B; Bae K
    J Nat Prod; 2010 Feb; 73(2):172-6. PubMed ID: 20039640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect on NO production of triterpenes from the fruiting bodies of Ganoderma lucidum.
    Tung NT; Cuong TD; Hung TM; Lee JH; Woo MH; Choi JS; Kim J; Ryu SH; Min BS
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1428-32. PubMed ID: 23357630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure characterization of a novel neutral polysaccharide isolated from Ganoderma lucidum fruiting bodies.
    Pan D; Wang L; Chen C; Teng B; Wang C; Xu Z; Hu B; Zhou P
    Food Chem; 2012 Dec; 135(3):1097-103. PubMed ID: 22953830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of Ganoderma lucidum.
    Fatmawati S; Shimizu K; Kondo R
    Fitoterapia; 2010 Dec; 81(8):1033-6. PubMed ID: 20603199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nor-triterpenoids from the fruiting bodies of
    Li D; Leng Y; Liao Z; Hu J; Sun Y; Deng S; Wang C; Tian X; Zhou J; Wang R
    Nat Prod Res; 2023 Feb; 37(4):579-585. PubMed ID: 35608196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sanguinones A and B, blue pyrroloquinoline alkaloids from the fruiting bodies of the mushroom Mycena sanguinolenta.
    Peters S; Spiteller P
    J Nat Prod; 2007 Aug; 70(8):1274-7. PubMed ID: 17658856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Cytotoxic Gymnomitrane Sesquiterpene from Ganoderma lucidum Fruiting Bodies.
    Binh PT; Descoutures D; Dang NH; Nguyen NP; Dat NT
    Nat Prod Commun; 2015 Nov; 10(11):1911-2. PubMed ID: 26749823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New triterpenoids from the fruiting bodies of Ganoderma lucidum and their bioactivities.
    Liu DZ; Zhu YQ; Li XF; Shan WG; Gao PF
    Chem Biodivers; 2014 Jun; 11(6):982-6. PubMed ID: 24934684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racemic alkaloids from the fungus Ganoderma cochlear.
    Wang XL; Dou M; Luo Q; Cheng LZ; Yan YM; Li RT; Cheng YX
    Fitoterapia; 2017 Jan; 116():93-98. PubMed ID: 27894905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural elucidation of the polysaccharide moiety of a glycopeptide (GLPCW-II) from Ganoderma lucidum fruiting bodies.
    Ye L; Zhang J; Ye X; Tang Q; Liu Y; Gong C; Du X; Pan Y
    Carbohydr Res; 2008 Mar; 343(4):746-52. PubMed ID: 18179790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelianthinarubins A and B, Red Pyrroloquinoline Alkaloids from the Fruiting Bodies of the Mushroom Mycena pelianthina.
    Pulte A; Wagner S; Kogler H; Spiteller P
    J Nat Prod; 2016 Apr; 79(4):873-8. PubMed ID: 27002340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory Effects of Highly Oxygenated Lanostane Derivatives from the Fungus Ganoderma lucidum on P-Glycoprotein and α-Glucosidase.
    Zhao XR; Huo XK; Dong PP; Wang C; Huang SS; Zhang BJ; Zhang HL; Deng S; Liu KX; Ma XC
    J Nat Prod; 2015 Aug; 78(8):1868-76. PubMed ID: 26222905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two new triterpenoids from fruiting bodies of fungus Ganoderma lucidum.
    Zhao ZZ; Yin RH; Chen HP; Feng T; Li ZH; Dong ZJ; Cui BK; Liu JK
    J Asian Nat Prod Res; 2015; 17(7):750-5. PubMed ID: 25631072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization and bioactivity evaluation of an acidic proteoglycan extract from Ganoderma lucidum fruiting bodies for PTP1B inhibition and anti-diabetes.
    Pan D; Wang L; Hu B; Zhou P
    Biopolymers; 2014 Jun; 101(6):613-23. PubMed ID: 24127303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological study on carboxymethylated (1→3)-α-D-glucans from fruiting bodies of Ganoderma lucidum.
    Wiater A; Paduch R; Choma A; Pleszczyńska M; Siwulski M; Dominik J; Janusz G; Tomczyk M; Szczodrak J
    Int J Biol Macromol; 2012 Dec; 51(5):1014-23. PubMed ID: 22947449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extraction of triterpenoids from fruiting [corrected] bodies of Ganoderma lucidum by supercritical fluid extraction].
    Song SH; Jia XB; Chen Y; Chen B; Wang LJ; Zhao CL
    Zhongguo Zhong Yao Za Zhi; 2008 Sep; 33(17):2104-7. PubMed ID: 19066051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucocontextins A-R, lanostane-type triterpenoids from Ganoderma leucocontextum.
    Zhao ZZ; Chen HP; Li ZH; Dong ZJ; Bai X; Zhou ZY; Feng T; Liu JK
    Fitoterapia; 2016 Mar; 109():91-8. PubMed ID: 26687559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum.
    Fatmawati S; Shimizu K; Kondo R
    Phytomedicine; 2011 Sep; 18(12):1053-5. PubMed ID: 21596546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.